Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13946832 | 0.94 | ELANE (0.34) | FAAHELANEMGLL | |
| SCHEMBL14517825 | 0.93 | ELANE (0.33) | FAAHELANEMGLL | |
| SCHEMBL13946799 | 0.92 | FAAH (0.32) | FAAHELANECASP1 | |
| SCHEMBL5427057 | 0.92 | ELANE (0.33) | FAAHELANEMGLLCASP1 | |
| SCHEMBL14517816 | 0.92 | ELANE (0.36) | FAAHELANE | |
| SCHEMBL14517824 | 0.91 | ELANE (0.34) | FAAHELANE | |
| SCHEMBL13946840 | 0.91 | ELANE (0.34) | FAAHELANE | |
| SCHEMBL14517827 | 0.91 | ELANE (0.32) | FAAHELANE | |
| SCHEMBL14517846 | 0.91 | ELANE (0.32) | FAAHELANE | |
| SCHEMBL14543064 | 0.91 | FAAH (0.33) | FAAHELANEMGLLCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090029964-A1 | Novel carbapenem compound | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| US-7205291-B2 | High mouth absorption; antibiotics against gramnegative, grampositive bacteria espscially Staphlococcus pneumonia, Hemophilus influenza | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-17 | — | — | US | disclosed |
| US-7205291-B2 | High mouth absorption; antibiotics against gramnegative, grampositive bacteria espscially Staphlococcus pneumonia, Hemophilus influenza | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090029964-A1 | Novel carbapenem compound | MGAM2, OXA1L, RIOX2 | FAAH 4035/4885ELANE 978/4885MGLL 2333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.